|
DE2951135A1
(de)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
DE3347565A1
(de)
|
1983-12-30 |
1985-07-11 |
Thomae Gmbh Dr K |
Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
JPS6354321A
(ja)
|
1985-03-27 |
1988-03-08 |
Ajinomoto Co Inc |
血糖降下剤
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
AU654331B2
(en)
|
1991-03-30 |
1994-11-03 |
Kissei Pharmaceutical Co. Ltd. |
Succinic acid compounds
|
|
US5155100A
(en)
|
1991-05-01 |
1992-10-13 |
Ciba-Geigy Corporation |
Phosphono/biaryl substituted dipeptide derivatives
|
|
RU2086544C1
(ru)
|
1991-06-13 |
1997-08-10 |
Хоффманн-Ля Рош АГ |
Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
|
|
DK0589874T3
(da)
|
1991-06-21 |
2000-04-03 |
Boehringer Ingelheim Pharma |
Anvendelse af (S) (+) -2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl ]aminocarbonylmethyl]-benzoesyre til fremstil
|
|
ES2100291T3
(es)
|
1991-07-30 |
1997-06-16 |
Ajinomoto Kk |
Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
|
|
WO1993011782A1
(en)
|
1991-12-19 |
1993-06-24 |
Southwest Foundation For Biomedical Research |
Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
|
|
CA2167818A1
(en)
*
|
1993-08-02 |
1995-02-09 |
Robert George Whittaker |
Therapeutic compound - fatty acid conjugates
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
TW313568B
(https=)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
KR20010033601A
(ko)
|
1997-12-24 |
2001-04-25 |
다케다 야쿠힌 고교 가부시키가이샤 |
폴리펩티드, 그의 제법 및 용도
|
|
WO1999043357A1
(en)
*
|
1998-02-25 |
1999-09-02 |
Micrologix Biotech Inc. |
Indolicidin and cationic peptides conjugated with polymers
|
|
US6197786B1
(en)
|
1998-09-17 |
2001-03-06 |
Pfizer Inc |
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
US6683113B2
(en)
|
1999-09-23 |
2004-01-27 |
Pharmacia Corporation |
(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
EP1270585B1
(en)
|
2000-03-23 |
2006-05-17 |
Takeda Chemical Industries, Ltd. |
Peptide derivative
|
|
HUP0301335A3
(en)
|
2000-04-12 |
2006-02-28 |
Novartis Ag |
Combination of organic compounds
|
|
WO2002085923A2
(en)
|
2001-04-19 |
2002-10-31 |
The Scripps Research Institute |
In vivo incorporation of unnatural amino acids
|
|
IL161677A0
(en)
|
2001-11-08 |
2004-09-27 |
Protein Design Labs |
Stable liquid pharmaceutical formulation of igg antibodies
|
|
WO2003104200A1
(en)
|
2002-06-07 |
2003-12-18 |
Glaxo Group Limited |
N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
|
|
DK1537114T3
(da)
|
2002-08-07 |
2006-11-13 |
Novartis Ag |
Organiske forbindelser som midler til behandling af aldosteronmedierede tilstande
|
|
CN100447142C
(zh)
|
2002-11-18 |
2008-12-31 |
诺瓦提斯公司 |
咪唑并[1,5a]吡啶衍生物及治疗醛固酮所介导疾病的方法
|
|
EP1626981A4
(en)
*
|
2003-03-04 |
2006-11-22 |
Biorexis Pharmaceutical Corp |
PROTEINS PROTECTED AGAINST DIPEPTIDYLPEPTIDASE
|
|
JP2007530550A
(ja)
|
2004-03-26 |
2007-11-01 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物および方法
|
|
UA90269C2
(ru)
|
2004-04-02 |
2010-04-26 |
Мицубиси Танабе Фарма Корпорейшн |
Тетрагидрохинолиновые производные и способ их получения
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
CA2568164A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
JP5179174B2
(ja)
|
2004-05-28 |
2013-04-10 |
ノバルティス ファーマ アーゲー |
アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ［１，５−ａ］ピリジン誘導体
|
|
WO2006005726A2
(en)
|
2004-07-09 |
2006-01-19 |
Speedel Experimenta Ag |
Heterocyclic compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US8673848B2
(en)
|
2012-01-27 |
2014-03-18 |
Novartis Ag |
Synthetic apelin mimetics for the treatment of heart failure
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
US8476239B2
(en)
|
2005-12-20 |
2013-07-02 |
Bristol-Myers Squibb Company |
Stable protein formulations
|
|
US20090156875A1
(en)
|
2006-04-04 |
2009-06-18 |
Takafumi Tomioka |
Methane separation method, methane separation apparatus, and methane utilization system
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
US8232403B2
(en)
|
2006-05-10 |
2012-07-31 |
Novartis Ag |
Bicyclic derivatives as CETP inhibitors
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
EP2049517B1
(en)
|
2006-07-20 |
2013-11-27 |
Novartis AG |
Amino-piperidine derivatives as cetp inhibitors
|
|
CA2660701A1
(en)
|
2006-08-25 |
2008-03-06 |
Novartis Ag |
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
|
|
PE20081140A1
(es)
*
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
EP2094669A2
(en)
|
2006-12-18 |
2009-09-02 |
Novartis AG |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
KR20090090395A
(ko)
|
2006-12-18 |
2009-08-25 |
노파르티스 아게 |
4-이미다졸릴-1,2,3,4-테트라히드로퀴놀린 유도체 및 알도스테론/11-베타-히드록실라제 억제제로서의 그의 용도
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
RU2009139811A
(ru)
|
2007-03-29 |
2011-05-10 |
Новартис АГ (CH) |
Гетероциклические спиросоединения
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
WO2009035543A1
(en)
|
2007-09-07 |
2009-03-19 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
CN101910150B
(zh)
|
2007-11-05 |
2013-09-18 |
诺瓦提斯公司 |
作为cetp抑制剂、可用于治疗疾病如高脂血症或动脉硬化的4-苄基氨基-1-羧基酰基哌啶衍生物
|
|
MX2010006063A
(es)
|
2007-12-03 |
2010-07-01 |
Novartis Ag |
Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
|
|
EP2297113A1
(en)
|
2008-04-29 |
2011-03-23 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
MX2011000847A
(es)
*
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
|
WO2010048582A1
(en)
|
2008-10-24 |
2010-04-29 |
Irm Llc |
Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
|
|
WO2010053545A2
(en)
*
|
2008-11-04 |
2010-05-14 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
|
NZ596302A
(en)
|
2009-05-15 |
2014-01-31 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
SG176009A1
(en)
|
2009-05-28 |
2011-12-29 |
Novartis Ag |
Substituted aminopropionic derivatives as neprilysin inhibitors
|
|
JP5466759B2
(ja)
|
2009-05-28 |
2014-04-09 |
ノバルティス アーゲー |
ネプリライシン阻害剤としての置換アミノ酪酸誘導体
|
|
US9345661B2
(en)
|
2009-07-31 |
2016-05-24 |
Genentech, Inc. |
Subcutaneous anti-HER2 antibody formulations and uses thereof
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
RS59459B1
(sr)
*
|
2010-01-22 |
2019-11-29 |
Novo Nordisk Healthcare Ag |
Hormoni rasta sa produženom in-vivo efikasnošću
|
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
JP6050746B2
(ja)
|
2010-05-13 |
2016-12-21 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
Ｇタンパク質共役受容体活性を示すグルカゴンスーパーファミリーのペプチド
|
|
SI3045183T1
(sl)
|
2011-03-11 |
2018-11-30 |
Genzyme Corporation |
Pegiliran Apelin in njegove uporabe
|
|
CN104254540A
(zh)
*
|
2012-01-09 |
2014-12-31 |
安科治疗公司 |
Apj受体化合物
|
|
US20160067347A1
(en)
|
2012-12-20 |
2016-03-10 |
Amgen Inc. |
Apj receptor agonists and uses thereof
|
|
US9353163B2
(en)
|
2013-03-14 |
2016-05-31 |
Regeneron Pharmaceuticals, Inc. |
Apelin fusion proteins and uses thereof
|
|
HK1218252A1
(zh)
*
|
2013-07-25 |
2017-02-10 |
Novartis Ag |
合成apelin多肽之生物结合物
|
|
KR20160031551A
(ko)
|
2013-07-25 |
2016-03-22 |
노파르티스 아게 |
심부전의 치료를 위한 시클릭 폴리펩티드
|
|
WO2015191781A2
(en)
|
2014-06-10 |
2015-12-17 |
Amgen Inc. |
Apelin polypeptides
|
|
US10588980B2
(en)
*
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
WO2016102648A1
(en)
|
2014-12-23 |
2016-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Metabolically stable apelin analogs in the treatment of disease mediated by the apelin receptor
|